Delivery Order SPE2DB24D8001-SPE2DB25FKZBM
Award Date
1/17/25
Potential Completion Date
1/21/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKYYJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc. The contract, valued at $10,413.85, is a firm-fixed-price delivery order for the supply of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product.
Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation that specializes in providing pharmaceutical products, medical...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $9,456.99 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with an ultimate completion date of October 18, 2024. This award is part of Dakota Drug, Inc.'s Indefinite Delivery Contract (IDC) SPE2DB24D8001 valued at $999,999,999.00, which allows the company to provide a comprehensive range...
The federal contract award SPE2DB24D8002|SPE2DB24FJMPZ was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The $11,567.65 Firm Fixed Price delivery order is for the pharmaceutical product STELARA 90 MG/ML SYRINGEML, with a performance period ending on July 19, 2024. This contract is not a set-aside award.
Dakota Drug, Inc. is an experienced federal contractor, holding a $999,999,999.00 Indefinite Delivery...
This federal contract award, identified as SPE2DB24D8002|SPE2DB24FJMUU, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $8,534.36 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML syringes, a prescription medication.
The award is not associated with a set-aside program. However, Dakota Drug, Inc. maintains its status as a small disadvantaged business,...
This federal contract award, with ID SPE2DB24D8001|SPE2DB24FKYWF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc. The $9,771.03 firm fixed-price delivery order is for the pharmaceutical product STELARA 90 MG/ML SYRINGEML. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S....
This federal contract award, with ID SPE2DB24D8001|SPE2DB24FKYYA, is a delivery order valued at $19,198.65 issued by the Defense Logistics Agency (DLA) to the prime contractor, Dakota Drug, Inc. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance through August 20, 2024. This award is not associated with a...
This federal contract award, identified as SPE2DB24D8002 and SPE2DB25FJMYQ, was granted to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The contract, valued at $14,948.19, is a firm-fixed-price delivery order for the supply of STELARA 90 MG/ML SYRINGEML pharmaceutical products.
Dakota Drug, Inc. is an established federal contractor, holding a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of STELARA 90 MG/ML syringes. The $8,236.05 contract has a performance period through January 16, 2025 and is not a set-aside award. Dakota Drug, Inc. is the prime contractor and this award is part of the DLA Troop Support Medical's ECAT Generation V Program, a large Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $7,823.07 firm fixed price delivery order is for the pharmaceutical product STELARA 90 MG/ML SYRINGE, with a completion date of January 8, 2024. Dakota Drug, Inc. has provided a range of pharmaceutical and medical products to the Department of Defense (DOD) through its...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, to the prime contractor Dakota Drug, Inc. The $9,826.08 firm fixed-price delivery order covers the supply of STELARA 90 MG/ML syringes, a biologic drug used to treat autoimmune conditions. The contract has a period of performance through May 30, 2024. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter...